Atlas Arteria (ASX:ALX) - Cotización, noticias y análisis

Resumen de acción ALX

Atlas Arteria Limited posee, desarrolla y explota autopistas de peaje.

Análisis fundamental de ALX
Puntuación del snowflake
Valoración	3/6
Crecimiento futuro	3/6
Rendimiento pasado	2/6
Salud financiera	3/6
Dividendos	4/6

Recompensas

Cotiza un 49.2% por debajo de nuestra estimación de su valor justo

Se prevé un crecimiento anual de los beneficios de 19.94%

Análisis de riesgos

El dividendo de 8.26% no está bien cubierto por las ganancias o los flujos de caja libres

Competidores de Atlas Arteria Limited

Transurban Group

ASX:TCL

AU$39.2b

Qube Holdings

ASX:QUB

AU$6.5b

Aurizon Holdings

ASX:AZJ

AU$6.1b

Dalrymple Bay Infrastructure

ASX:DBI

AU$1.7b

Historial de precios y rendimiento

Resumen de todos los máximos históricos, cambios y caídas de precios de Atlas Arteria
Precios históricos de las acciones
Precio actual de la acción	AU$4.84
Máximo en las últimas 52 semanas	AU$6.07
Mínimo de 52 semanas	AU$4.63
Beta	0.78
1Cambio en 1 mes	0.62%
Variación en 3 meses	-6.92%
Cambio de 1 año	-14.18%
3Variación en 3 años	-21.94%
Variación en 5 años	-37.55%
Variación desde la OPV	686.99%

Noticias y actualizaciones recientes

Recent updates

Is Now An Opportune Moment To Examine Atlas Arteria Limited (ASX:ALX)?

Apr 07

What Does Atlas Arteria Limited's (ASX:ALX) Share Price Indicate?

Dec 22

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 43% Undervaluation?

Aug 10

Is Atlas Arteria (ASX:ALX) Using Too Much Debt?

May 31

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 48% Undervaluation?

Apr 14

Debra Goodin Is The Independent Chairman of the Board of Atlas Arteria Limited (ASX:ALX) And They Just Picked Up 54% More Shares

Mar 03

Here's Why Atlas Arteria (ASX:ALX) Can Afford Some Debt

Feb 27

Atlas Arteria (ASX:ALX) Has Compensated Shareholders With A Respectable 78% Return On Their Investment

Jan 31

Atlas Arteria Limited (ASX:ALX) Shares Could Be 44% Below Their Intrinsic Value Estimate

Dec 27

How Many Atlas Arteria Limited (ASX:ALX) Shares Do Institutions Own?

Dec 06

Is There Now An Opportunity In Atlas Arteria Limited (ASX:ALX)?

Nov 19

Atlas Arteria (ASX:ALX) Has Gifted Shareholders With A Fantastic 142% Total Return On Their Investment

Jul 30

Rentabilidad de los accionistas

	ALX	AU Infrastructure	Mercado AU
7D	-2.6%	-2.2%	-1.1%
1Y	-14.2%	2.6%	16.1%

Rentabilidad vs. Industria: Los resultados de ALX fueron inferiores a los de la industria Australian Infrastructure, que obtuvo un rendimiento del 2.6% el año pasado.

Rentabilidad vs. Mercado: ALX obtuvo unos resultados inferiores a los del mercado Australian, que fueron del 16.1% el año pasado.

Volatilidad de los precios

Is ALX's price volatile compared to industry and market?
ALX volatility
ALX Average Weekly Movement	3.1%
Infrastructure Industry Average Movement	2.6%
Market Average Movement	8.7%
10% most volatile stocks in AU Market	17.7%
10% least volatile stocks in AU Market	3.6%

Precio estable de las acciones: ALX no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de ALX (3%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

Fundada	Empleados	CEO	Página web
2009	n/a	Graeme Bevans	www.atlasarteria.com

Atlas Arteria Limited posee, desarrolla y explota autopistas de peaje. Posee una participación del 31,14% en las APRR y A79 y del 31,17% en la ADELAC situadas en Francia; una participación del 100% en el túnel Warnow situado en Rostock, Alemania; una participación del 66,67% en la Chicago Skyway situada en Chicago y una participación del 100% en la Dulles Greenway situada en Virginia, Estados Unidos. La empresa era conocida anteriormente como Macquarie Atlas Roads Limited y cambió su nombre a Atlas Arteria Limited en mayo de 2018.

Resumen de fundamentos de Atlas Arteria Limited

¿Cómo se comparan los beneficios e ingresos de Atlas Arteria con su capitalización de mercado?
Estadísticas fundamentales de ALX
Capitalización bursátil	AU$7.02b
Beneficios(TTM)	AU$300.20m
Ingresos (TTM)	AU$140.10m

23.4x

Ratio precio-beneficio (PE)

50.1x

Ratio precio-ventas (PS)

¿Está ALX sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de ALX
Ingresos	AU$140.10m
Coste de los ingresos	AU$47.80m
Beneficio bruto	AU$92.30m
Otros gastos	-AU$207.90m
Beneficios	AU$300.20m

Últimos beneficios comunicados

Jun 30, 2024

Próxima fecha de beneficios

Feb 26, 2025

Beneficios por acción (BPA)	0.21
Margen bruto	65.88%
Margen de beneficio neto	214.28%
Ratio deuda/patrimonio	27.2%

¿Cómo se ha desempeñado ALX a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

8.3%

Rentabilidad actual por dividendo

194%

Ratio de pagos

Resumen de acción ALX

Recompensas

Análisis de riesgos

Competidores de Atlas Arteria Limited

ASX:TCL

AU$39.2b

ASX:QUB

AU$6.5b

ASX:AZJ

AU$6.1b

ASX:DBI

AU$1.7b

Historial de precios y rendimiento

Noticias y actualizaciones recientes

First half dividend of AU$0.20 announced

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024

High number of new directors

Consensus revenue estimates fall by 13%

First half 2024 earnings: EPS and revenues miss analyst expectations

Now 20% undervalued after recent price drop

Recent updates

First half dividend of AU$0.20 announced

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024

High number of new directors

Consensus revenue estimates fall by 13%

First half 2024 earnings: EPS and revenues miss analyst expectations

Now 20% undervalued after recent price drop

Atlas Arteria Limited Appoints Hugh Wehby as Managing Director

Atlas Arteria Limited to Report First Half, 2025 Results on Aug 28, 2025

Final dividend of AU$0.20 announced

Atlas Arteria Limited Announces the Retirement of Graeme Bevans as CEO and Managing Director

Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2023, Payable on 8 April 2024

Atlas Arteria Limited, Annual General Meeting, May 15, 2024

Atlas Arteria Limited, Annual General Meeting, May 16, 2024

Full year 2023 earnings released: EPS: AU$0.22 (vs AU$0.25 in FY 2022)

Atlas Arteria Appoints Laura Hendricks to the Board as an Independent Non-Executive Director

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Estimated Payment Date Is 5 October 2023

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Payable on 5 October 2023

Consensus EPS estimates fall by 11%

First half 2023 earnings released: EPS: AU$0.12 (vs AU$0.13 in 1H 2022)

Atlas Arteria Limited Reaffirms Distribution Guidance for the First Half and Second Half of 2023

Atlas Arteria Limited to Report First Half, 2024 Results on Aug 29, 2024

Atlas Arteria Limited Appoints Ken Daley as Director

Atlas Arteria Limited Announces Caroline Foulger Will Retire as A Director, with Effect from 1 July 2023

Consensus EPS estimates fall by 15%

Full year 2022 earnings released: EPS: AU$0.25 (vs AU$0.19 in FY 2021)

Insufficient new directors

Atlas Arteria Limited Announces Board Changes

Atlas Arteria Limited (ASX:ALX) completed the acquisition of 66.67% stake in Skyway Concession Company, LLC from CPP Investments and OMERS Infrastructure.

Now 20% undervalued after recent price drop

Atlas Arteria Limited, Annual General Meeting, Apr 27, 2023

Consensus revenue estimates increase by 10%

Atlas Arteria Limited to Report Q4, 2022 Results on Feb 23, 2023

Price target decreased to AU$6.96

Investor sentiment deteriorated over the past week

Atlas Arteria Limited Provides Distribution Guidance for the Year 2023

Atlas Arteria Limited (ASX:ALX) entered into an agreement to acquire a 66.67% stake in Skyway Concession Company, LLC for $2 billion.

Consensus EPS estimates fall by 14%

First half 2022 earnings released: EPS: AU$0 (vs AU$0.074 in 1H 2021)

Atlas Arteria Limited Provides Dividend Guidance for the First Half of 2022

Price target increased to AU$7.40

Investor sentiment improved over the past week

Atlas Arteria Limited Announces Executive Changes

Is Now An Opportune Moment To Examine Atlas Arteria Limited (ASX:ALX)?

Independent Non-Executive Director recently bought AU$76k worth of stock

Full year 2021 earnings: EPS and revenues miss analyst expectations

What Does Atlas Arteria Limited's (ASX:ALX) Share Price Indicate?

Insider recently bought AU$67k worth of stock

First half 2021 earnings released: EPS AU$0.074 (vs AU$0.14 loss in 1H 2020)

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 43% Undervaluation?

Is Atlas Arteria (ASX:ALX) Using Too Much Debt?

Price target decreased to AU$6.21

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 48% Undervaluation?

Debra Goodin Is The Independent Chairman of the Board of Atlas Arteria Limited (ASX:ALX) And They Just Picked Up 54% More Shares

Independent Chairman of the Board recently bought AU$100k worth of stock

Here's Why Atlas Arteria (ASX:ALX) Can Afford Some Debt

Full year 2020 earnings released: AU$0.061 loss per share (vs AU$0.024 profit in FY 2019)

Atlas Arteria Limited Announces Board Changes

New 90-day low: AU$5.97

Atlas Arteria Limited to Report Fiscal Year 2020 Results on Feb 25, 2021